rs374351172
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018249.6(CDK5RAP2):c.4546G>T(p.Glu1516*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018249.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive primary microcephalyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- microcephaly 3, primary, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- corpus callosum, agenesis ofInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018249.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDK5RAP2 | NM_018249.6 | MANE Select | c.4546G>T | p.Glu1516* | stop_gained | Exon 30 of 38 | NP_060719.4 | ||
| CDK5RAP2 | NM_001410994.1 | c.4543G>T | p.Glu1515* | stop_gained | Exon 30 of 38 | NP_001397923.1 | |||
| CDK5RAP2 | NM_001410993.1 | c.4450G>T | p.Glu1484* | stop_gained | Exon 29 of 37 | NP_001397922.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDK5RAP2 | ENST00000349780.9 | TSL:1 MANE Select | c.4546G>T | p.Glu1516* | stop_gained | Exon 30 of 38 | ENSP00000343818.4 | ||
| CDK5RAP2 | ENST00000360190.8 | TSL:1 | c.4546G>T | p.Glu1516* | stop_gained | Exon 30 of 37 | ENSP00000353317.4 | ||
| CDK5RAP2 | ENST00000473282.6 | TSL:1 | n.*3370G>T | non_coding_transcript_exon | Exon 31 of 39 | ENSP00000419265.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251364 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461424Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727020 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74378 show subpopulations
ClinVar
Submissions by phenotype
Microcephaly 3, primary, autosomal recessive Pathogenic:3
PVS1,PM2,PP5
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5.
not provided Pathogenic:1
CDK5RAP2-related disorder Pathogenic:1
The CDK5RAP2 c.4546G>T variant is predicted to result in premature protein termination (p.Glu1516*). This variant has been reported in individuals with autosomal recessive microcephaly (Boonsawat et al. 2019. PubMed ID: 30842647; Nasser et al. 2020. PubMed ID: 32015000). This variant is reported in 0.0053% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in CDK5RAP2 are expected to be pathogenic. Given the evidence, we interpret c.4546G>T (p.Glu1516*) as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at